ArticleJournal of endocrinological investigation2025
Association of plasma Irisin levels with executive function in children: the role of weight status.
Article in Journal of endocrinological investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Protective Role of Physical Exercise and Exercise-Induced FNDC5/Irisin in Combating Diabetes-Related Cognitive Impairment and Autonomic and Peripheral Neuropathies: A Comprehensive Review.Journal of diabetes research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeIrisin, an adipokine closely correlated with metabolism, may affect adults' executive function (EF). But little is known about this association in school-aged children, particularly regarding differences across weight status (i.e., thinness, normal-weight, overweight/obesity). Therefore, we aimed to examine the associations of irisin with EFs in school-aged children, and further explore whether weight status modifies these correlations.
methodsChildren aged 7-12 years were recruited from five schools in 2017 in Guangzhou, China. Plasma irisin levels were assessed using an enzyme-linked immunosorbent assay. EFs were assessed using the Stroop Color-Word test (inhibitory control), Corsi Block-Tapping task (working memory), and Wisconsin Card Sorting test (cognitive flexibility). Children's weight status was objectively measured and classified into three groups. Multivariable linear regression was performed, with stratified analysis by weight status.
resultsA total of 502 children were included. In the overall sample, no significant associations between irisin and EFs in children were found. However, higher irisin levels were significantly associated with better Stroop Color-Word test performance among children with overweight/obesity (response time: β = -0.129, 95%CI: -0.228, -0.030; word interference time: β = -0.088, 95%CI: -0.163, -0.013). Null significant associations in the groups with thinness or normal-weight were found. Weight status significantly modified the associations of irisin with EFs (P
conclusionsChildren with overweight/obesity might be more sensitive to the effect of irisin on EFs, especially on inhibitory control. Irisin might be a promising target to promote EF development in overweight/obese children.
Indexed as
Identifiers
40063197What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.